Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1888625
PUBLISHER: Grand View Research | PRODUCT CODE: 1888625
Middle East Imaging Biomarkers Market Size, Share & Trends Analysis Report By Biomarkers (Molecular/Nuclear Biomarkers), By Imaging Technology, By Application, By End Use, By Country, And Segment Forecasts, 2025 - 2033
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Market Size & Trends:
The Middle East imaging biomarkers market size was estimated at USD 413.74 million in 2024 and is projected to reach USD 1,131.80 million by 2033, growing at a CAGR of 12.27% from 2025 to 2033. The expansion of advanced imaging infrastructure (MRI, PET/CT) and the greater adoption of biomarker-driven clinical pathways are shifting care from empiric to data-driven approaches.
This structural shift-driven by national healthcare strategies, increased public and private healthcare spending, and programs aimed at attracting clinical trials-creates a growing addressable market for imaging biomarkers used in oncology, neurology, and cardiology.
The growing prevalence of chronic and lifestyle-related diseases is one of the most significant drivers of the Middle East imaging biomarkers industry. The region has seen a rapid rise in cancer, cardiovascular, and neurological disorders due to aging populations, sedentary lifestyles, and dietary changes. According to WHO data, noncommunicable diseases account for over 70% of total deaths in GCC countries, increasing the need for early detection and precise diagnosis. Imaging biomarkers-used in PET, MRI, and CT modalities-play a vital role in identifying disease progression at the molecular levels. This surge in chronic disease prevalence has, therefore, heightened demand for advanced imaging technologies that rely on biomarker data for early and accurate diagnosis.
Increasing healthcare expenditure and infrastructure development are also accelerating market growth. Countries such as Saudi Arabia, the UAE, and Qatar are investing heavily in advanced diagnostic centers, imaging equipment, and hospital modernization as part of their national health transformation programs. For example, Saudi Arabia's Vision 2030 allocates substantial funds to expand digital and diagnostic healthcare capabilities, while the UAE continues to position itself as a regional hub for precision medicine and advanced diagnostics. This sustained increase in healthcare spending-estimated to grow at over 7% annually across the GCC-enhances accessibility to imaging biomarker technologies and fuels adoption across both public and private sectors.
Middle East Imaging Biomarkers Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East imaging biomarkers market report based on biomarkers, imaging technology, application, end use, and country:
- Biomarkers Outlook (Revenue, USD Million, 2021 - 2033)
- Anatomical biomarkers
- Functional biomarkers
- Molecular/Nuclear Biomarkers
- Quantitative Imaging Biomarkers
- Others
- Imaging Technology Outlook (Revenue, USD Million, 2021 - 2033)
- MRI
- CT
- PET
- SPECT
- Ultrasound
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Disease Risk Assessment
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Diagnostic/imaging centers
- Pharmaceutical and Biotech Companies
- Others
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- Middle East
- Saudi Arabia
- UAE
- Kuwait
- Oman
- Qatar
Product Code: GVR-4-68040-798-3
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Biomarkers
- 1.2.2. Imaging Technology
- 1.2.3. Application
- 1.2.4. End Use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising demand for early diagnosis and personalized medicine
- 3.2.1.2. Advancements in imaging and molecular biomarker technologies
- 3.2.1.3. Regulatory approvals supporting clinical adoption
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of imaging equipment and diagnostic tests
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Middle East Imaging Biomarkers Market: Biomarkers Business Analysis
- 4.1. Segment Dashboard
- 4.2. Middle East Imaging Biomarkers Market Biomarkers Movement Analysis
- 4.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Biomarkers, 2021 to 2033(USD Million)
- 4.4. Anatomical Biomarkers
- 4.4.1. Anatomical Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Functional Biomarkers
- 4.5.1. Functional Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Molecular/Nuclear Biomarkers
- 4.6.1. Molecular/Nuclear Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Quantitative Imaging Biomarkers
- 4.7.1. Quantitative Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.8. Others
- 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Imaging Biomarkers Market: Imaging Technology Business Analysis
- 5.1. Segment Dashboard
- 5.2. Middle East Imaging Biomarkers Market Imaging Technology, Movement Analysis
- 5.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Imaging Technology, 2021 to 2033(USD Million)
- 5.4. MRI
- 5.4.1. MRI Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. CT
- 5.5.1. CT Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. PET
- 5.6.1. PET Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. SPECT
- 5.7.1. SPECT Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Ultrasound
- 5.8.1. Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Others
- 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Imaging Biomarkers Market: Application Business Analysis
- 6.1. Segment Dashboard
- 6.2. Middle East Imaging Biomarkers Market Application Movement Analysis
- 6.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Application, 2021 to 2033(USD Million)
- 6.4. Diagnostics
- 6.4.1. Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Drug Discovery & Development
- 6.5.1. Drug Discovery & Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Personalized Medicine
- 6.6.1. Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Disease Risk Assessment
- 6.7.1. Disease Risk Assessment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Others
- 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Imaging Biomarkers Market: End Use Business Analysis
- 7.1. Segment Dashboard
- 7.2. Middle East Imaging Biomarkers Market End Use Movement Analysis
- 7.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by End Use, 2021 to 2033(USD Million)
- 7.4. Hospitals
- 7.4.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Diagnostic/imaging centers
- 7.5.1. Diagnostic/imaging centers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Pharmaceutical and Biotech Companies
- 7.6.1. Pharmaceutical and Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Others
- 7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East Imaging Biomarkers Market: Country Estimates & Trend Analysis by Biomarkers, Imaging Technology, Application & End Use
- 8.1. Country Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 8.3. Middle east
- 8.3.1. Middle East Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. Saudi Arabia
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. Saudi Arabia Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. UAE
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. UAE Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.4. Kuwait
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Kuwait Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.5. Oman
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Oman Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.6. Qatar
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Qatar Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Participant Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2024
- 9.4. Participant's Overview
- 9.4.1. GE HealthCare
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Biomarkers Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. FUJIFILM Holdings Corporation
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Biomarkers Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Siemens Healthineers AG
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Biomarkers Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Lunit Inc.
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Biomarkers Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Median Technologies
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Biomarkers Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. BioClinica Inc.
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Biomarkers Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. ICON plc
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Biomarkers Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Bracco
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Biomarkers Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Philips Healthcare
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Biomarkers Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.1. GE HealthCare
Product Code: GVR-4-68040-798-3
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 Middle East imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
- Table 4 Middle East imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
- Table 5 Middle East imaging biomarkers market, by application, 2021 - 2033 (USD Million)
- Table 6 Middle East imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
- Table 7 Middle East imaging biomarkers market, by country, 2021 - 2033 (USD Million)
- Table 8 Saudi Arabia imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
- Table 9 Saudi Arabia imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
- Table 10 Saudi Arabia imaging biomarkers market, by application, 2021 - 2033 (USD Million)
- Table 11 Saudi Arabia imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
- Table 12 UAE imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
- Table 13 UAE imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
- Table 14 UAE imaging biomarkers market, by application, 2021 - 2033 (USD Million)
- Table 15 UAE imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
- Table 16 Kuwait imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
- Table 17 Kuwait imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
- Table 18 Kuwait imaging biomarkers market, by application, 2021 - 2033 (USD Million)
- Table 19 Kuwait imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
- Table 20 Oman imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
- Table 21 Oman imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
- Table 22 Oman imaging biomarkers market, by application, 2021 - 2033 (USD Million)
- Table 23 Oman imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
- Table 24 Qatar imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
- Table 25 Qatar imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
- Table 26 Qatar imaging biomarkers market, by application, 2021 - 2033 (USD Million)
- Table 27 Qatar imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
- Table 28 Participant's overview
- Table 29 Financial performance
- Table 30 Key companies undergoing expansions
- Table 31 Key companies undergoing acquisitions
- Table 32 Key companies undergoing collaborations
- Table 33 Key companies launching new products
- Table 34 Key companies undertaking other strategies
List of Figures
- Fig. 1 Imaging Biomarkers market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Market formulation & validation
- Fig. 7 Market outlook
- Fig. 8 Segment snapshot
- Fig. 9 Competitive landscape snapshot
- Fig. 10 Parent market outlook
- Fig. 11 Middle East imaging biomarkers market driver analysis
- Fig. 12 Middle East imaging biomarkers market restraint analysis
- Fig. 13 Middle East imaging biomarkers market: Porter's analysis
- Fig. 14 Middle East imaging biomarkers market: PESTEL analysis
- Fig. 15 Middle East imaging biomarkers market: Biomarkers outlook and key takeaways
- Fig. 16 Middle East imaging biomarkers market: Biomarkers market share analysis, 2023 - 2033
- Fig. 17 Middle East imaging biomarkers by anatomical biomarkers market, 2021 - 2033 (USD Million)
- Fig. 18 Middle East imaging biomarkers by functional biomarkers market, 2021 - 2033 (USD Million)
- Fig. 19 Middle East imaging biomarkers by molecular/nuclear biomarkers market, 2021 - 2033 (USD Million)
- Fig. 20 Middle East imaging biomarkers, by quantitative, 2021 - 2033 (USD Million)
- Fig. 21 Middle East imaging biomarkers, by other market, 2021 - 2033 (USD Million)
- Fig. 22 Imaging Biomarkers market: Imaging Technology outlook and key takeaways
- Fig. 23 Imaging Biomarkers market: Imaging Technology market share analysis, 2023 - 2033
- Fig. 24 Middle East imaging biomarkers by therapeutic drug monitoring market, 2021 - 2033 (USD Million)
- Fig. 25 Middle East imaging biomarkers by MRI market, 2021 - 2033 (USD Million)
- Fig. 26 Middle East imaging biomarkers by CT market, 2021 - 2033 (USD Million)
- Fig. 27 Middle East imaging biomarkers by PET market, 2021 - 2033 (USD Million)
- Fig. 28 Middle East imaging biomarkers by SPECT market, 2021 - 2033 (USD Million)
- Fig. 29 Middle East imaging biomarkers by Ultrasound market, 2021 - 2033 (USD Million)
- Fig. 30 Middle East imaging biomarkers by others market, 2021 - 2033 (USD Million)
- Fig. 31 Imaging Biomarkers market: Application outlook and key takeaways
- Fig. 32 Imaging Biomarkers market: Application market share analysis, 2023 - 2033
- Fig. 33 Middle East imaging biomarkers by diagnostics market, 2021 - 2033 (USD Million)
- Fig. 34 Middle East imaging biomarkers by Drug Discovery & Development market, 2021 - 2033 (USD Million)
- Fig. 35 Middle East imaging biomarkers by Personalized Medicine market, 2021 - 2033 (USD Million)
- Fig. 36 Middle East imaging biomarkers by Disease Risk Assessment market, 2021 - 2033 (USD Million)
- Fig. 37 Middle East imaging biomarkers by others market, 2021 - 2033 (USD Million)
- Fig. 38 Imaging Biomarkers market: End Use outlook and key takeaways
- Fig. 39 Imaging Biomarkers market: End Use market share analysis, 2023 - 2033
- Fig. 40 Middle East imaging biomarkers by hospitals market, 2021 - 2033 (USD Million)
- Fig. 41 Middle East imaging biomarkers by diagnostics centres market, 2021 - 2033 (USD Million)
- Fig. 42 Middle East imaging biomarkers by pharmaceutical and biotech companies market, 2021 - 2033 (USD Million)
- Fig. 43 Middle East imaging biomarkers by others market, 2021 - 2033 (USD Million)
- Fig. 44 Middle East imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 45 Saudi Arabia imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 46 UAE imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 47 Kuwait imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 48 Qatar imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 49 Oman imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 50 Key company categorization
- Fig. 51 Company market positioning
- Fig. 52 Market participant categorization
- Fig. 53 Strategy framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.